#biotech #roswellbiotech #moleculartech

Paul Mola is the Chief Executive Officer and President of Roswell Biotechnologies, Inc., and a member of the company’s board of directors. He founded Roswell in 2014, bringing more than 20 years of life science industry leadership and executive experience to the company.  Previously, Mr. Mola was Head of Global Solutions at Human Longevity, Inc., working with genome sequencing pioneer Craig Venter to establish international precision medicine partnerships. Prior to that, he spent over a decade at Life Technologies / Applied Biosystems (now part of ThermoFisher Scientific), the global leader in life science tools, and the historical market leader in DNA sequencing technology, where he was President of the Enterprise Genomic Solutions Business Unit and Head of Strategy and Chief of Staff for the Genetic Systems Division. In these roles, he managed strategy and international, large-scale business engagements for the entire DNA Sequencing Technology portfolio. Mr. Mola received the Life Technologies’ “Game Changer” award, the company’s highest honor for work that transforms the company, for his accomplishments which included establishing the national genome sequencing program for the government of Saudi Arabia, driving the acquisition of the Ion Torrent sequencing platform, leading the commercialization of the SOliD sequencing platform, and developing the business strategy for the Genia sequencing platform (later acquired by Roche).  Earlier in his career, Mr. Mola served in product development, sales, and marketing roles at Roche.  He holds a post-graduate degree in Biotechnology and Business.

https://www.linkedin.com/in/paul-mola 

https://twitter.com/paul_mola_ 

https://www.roswellbiotech.com/

Kindly Subscribe to CHANGE- I M POSSIBLE youtube channel

www.youtube.com/ctipodcast